Advanced search
Publication Cover
Leukemia & Lymphoma Volume 49, 2008 - Issue 1
Submit an article Journal homepage
226
Views
29
CrossRef citations to date
0
Altmetric
Letter to the Editor

B-cell depletion for 2 years after autologous stem cell transplant for NHL induces prolonged hypogammaglobulinemia beyond the rituximab maintenance period

Seah H. Lim Stem Cell Transplant Program, Texas Oncology, Northwest Texas Healthcare System and Cancer Research Program, Harrington Regional Medical Center, Amarillo, Texas, USACorrespondence[email protected]
, MD,
William V. Esler Stem Cell Transplant Program, Texas Oncology, Northwest Texas Healthcare System and Cancer Research Program, Harrington Regional Medical Center, Amarillo, Texas, USA
,
Yana Zhang Stem Cell Transplant Program, Texas Oncology, Northwest Texas Healthcare System and Cancer Research Program, Harrington Regional Medical Center, Amarillo, Texas, USA
,
Jian Zhang Stem Cell Transplant Program, Texas Oncology, Northwest Texas Healthcare System and Cancer Research Program, Harrington Regional Medical Center, Amarillo, Texas, USA
,
Phillip O. Periman Stem Cell Transplant Program, Texas Oncology, Northwest Texas Healthcare System and Cancer Research Program, Harrington Regional Medical Center, Amarillo, Texas, USA
,
Colleen Burris Stem Cell Transplant Program, Texas Oncology, Northwest Texas Healthcare System and Cancer Research Program, Harrington Regional Medical Center, Amarillo, Texas, USA
&
Mary Townsend Stem Cell Transplant Program, Texas Oncology, Northwest Texas Healthcare System and Cancer Research Program, Harrington Regional Medical Center, Amarillo, Texas, USA
 show all
Pages 152-153 | Received 05 Oct 2007, Accepted 08 Oct 2007, Published online: 01 Jul 2009

Citations (29)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Evangelos A.A. Christou, Giuliana Giardino, Austen Worth & Fani Ladomenou. (2017) Risk factors predisposing to the development of hypogammaglobulinemia and infections post-Rituximab. International Reviews of Immunology 36:6, pages 352-359.
Read now
Sally Arai & David B Miklos. (2010) Rituximab in hematopoietic cell transplantation. Expert Opinion on Biological Therapy 10:6, pages 971-982.
Read now

Articles from other publishers (27)

Ilias Pessach & Arnon Nagler. (2023) Leukapheresis for CAR-T cell production and therapy. Transfusion and Apheresis Science 62:6, pages 103828.
Crossref
Dayana Nasr, Prashanth Ashok Kumar, Maroun Bou Zerdan, Ghanshyam Ghelani, Dibyendu Dutta, Stephen Graziano & Seah H. Lim. (2022) Radioimmunoconjugates in the age of modern immuno-oncology. Life Sciences 310, pages 121126.
Crossref
William A. Langley, Andreas Wieland, Hasan Ahmed, Mohammed Ata ur Rasheed, Carl W. Davis, Jaturong Sewatanon, Scott N. Mueller, Mark J. Shlomchik, Veronika I. Zarnitsyna, Rustom Antia & Rafi Ahmed. (2022) Persistence of Virus-Specific Antibody after Depletion of Memory B Cells. Journal of Virology 96:9.
Crossref
Iris M. Otani, Heather K. Lehman, Artemio M. Jongco, Lulu R. Tsao, Antoine E. Azar, Teresa K. Tarrant, Elissa Engel, Jolan E. Walter, Tho Q. Truong, David A. Khan, Mark Ballow, Charlotte Cunningham-Rundles, Huifang Lu, Mildred Kwan & Sara Barmettler. (2022) Practical guidance for the diagnosis and management of secondary hypogammaglobulinemia: A Work Group Report of the AAAAI Primary Immunodeficiency and Altered Immune Response Committees. Journal of Allergy and Clinical Immunology 149:5, pages 1525-1560.
Crossref
Fabrizio Di Maida, Lorenzo Viola, Luca Lambertini, Andrea Mari, Jessica Mencarini, Beatrice Borchi, Marco Carini, Lorenzo Zammarchi & Andrea Minervini. (2021) A rare urinary JC virus reactivation after long-term therapy with rituximab. International Journal of Infectious Diseases 103, pages 447-449.
Crossref
Kathryn A. Culos, Katie S. Gatwood & Michael Byrne. (2020) Maintenance Strategies After Hematopoietic Cell Transplantation. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 40:8, pages 727-740.
Crossref
Yuhua Ru, Jia Chen & Depei Wu. (2018) Epstein-Barr virus post-transplant lymphoproliferative disease (PTLD) after hematopoietic stem cell transplantation. European Journal of Haematology 101:3, pages 283-290.
Crossref
Julio C. Chavez & Frederick L. Locke. (2018) CAR T cell therapy for B-cell lymphomas. Best Practice & Research Clinical Haematology 31:2, pages 135-146.
Crossref
Julio C. Chavez & Frederick L. Locke. (2017) A Possible Cure for Refractory DLBCL: CARs Are Headed in the Right Direction. Molecular Therapy 25:10, pages 2241-2243.
Crossref
N Epperla, T S Fenske, H M Lazarus & M Hamadani. (2015) Post-autologous transplant maintenance therapies in lymphoid malignancies: are we there yet?. Bone Marrow Transplantation 50:11, pages 1393-1404.
Crossref
N. L. Berinstein, S. Bhella, N. M. Pennell, M. C. Cheung, K. R. Imrie, D. E. Spaner, V. Milliken, L. Zhang, K. Hewitt, A. Boudreau, M. D. Reis, A. Chesney, D. Good, Z. Ghorab, L. K. Hicks, E. Piliotis & R. Buckstein. (2015) Prolonged clinical remissions in patients with relapsed or refractory follicular lymphoma treated with autologous stem cell transplantation incorporating rituximab. Annals of Hematology 94:5, pages 813-823.
Crossref
Yuan-Rong Ren, Yong-Dong Jin, Zhi-Hui Zhang, Li Li & Ping Wu. (2015) Rituximab Treatment Strategy for Patients with Diffuse Large B-Cell Lymphoma after First-Line Therapy. Chinese Medical Journal 128:3, pages 378-383.
Crossref
Darren M. Roberts, Rachel B. Jones, Rona M. Smith, Federico Alberici, Dinakantha S. Kumaratne, Stella Burns & David R.W. Jayne. (2015) Rituximab-associated hypogammaglobulinemia: Incidence, predictors and outcomes in patients with multi-system autoimmune disease. Journal of Autoimmunity 57, pages 60-65.
Crossref
Darren M. Roberts, Rachel B. Jones, Rona M. Smith, Federico Alberici, Dinakantha S. Kumaratne, Stella Burns & David R.W. Jayne. (2015) Immunoglobulin G replacement for the treatment of infective complications of rituximab-associated hypogammaglobulinemia in autoimmune disease: A case series. Journal of Autoimmunity 57, pages 24-29.
Crossref
Jennifer Worch, Olga Makarova & Birgit Burkhardt. (2015) Immunreconstitution and Infectious Complications After Rituximab Treatment in Children and Adolescents: What Do We Know and What Can We Learn from Adults?. Cancers 7:1, pages 305-328.
Crossref
Lawrence G. Lum, Archana Thakur, Qin Liu, Abhinav Deol, Zaid Al-Kadhimi, Lois Ayash, Muneer H. Abidi, Cassara Pray, Elyse N. Tomaszewski, Patricia A. Steele, Dana L. Schalk, Hiroshi Yano, Alice Mitchell, Melissa Dufresne, Joseph P. Uberti & Voravit Ratanatharathorn. (2013) CD20-Targeted T Cells after Stem Cell Transplantation for High Risk and Refractory Non-Hodgkin's Lymphoma. Biology of Blood and Marrow Transplantation 19:6, pages 925-933.
Crossref
Ruth PettengellNorbert SchmitzChristian GisselbrechtGraeme SmithWilliam N. PattonBernd MetznerDolores CaballeroHerve TillyJan A. WalewskiIsabelle Bence-BrucklerBik ToChristian H. GeislerRik SchotsEva KimbyChristian J. TavernaTomáš KozákPeter DregerRuzena UddinCarmen Ruiz de ElviraAnthony H. Goldstone. (2013) Rituximab Purging and/or Maintenance in Patients Undergoing Autologous Transplantation for Relapsed Follicular Lymphoma: A Prospective Randomized Trial From the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. Journal of Clinical Oncology 31:13, pages 1624-1630.
Crossref
Aditi Sinha & Arvind Bagga. (2013) Rituximab therapy in nephrotic syndrome: implications for patients' management. Nature Reviews Nephrology 9:3, pages 154-169.
Crossref
Anne Isvy, Marine Meunier, Gobeaux-Chenevier Camille, Emilie Maury, Julien Wipff, Chantal Job-Deslandre, Andr? Kahan & Yannick Allanore. (2012) Tol?rance du rituximab dans la polyarthrite rhumato?de?: exp?rience monocentrique du suivi au long cours des concentrations s?riques de gammaglobulines et de la survenue d?infection. Revue du Rhumatisme 79:4, pages 312-316.
Crossref
Anne Isvy, Marine Meunier, Camille Gobeaux-Chenevier, Emilie Maury, Julien Wipff, Chantal Job-Deslandre, Andr? Kahan & Yannick Allanore. (2012) Safety of rituximab in rheumatoid arthritis: A long-term prospective single-center study of gammaglobulin concentrations and infections. Joint Bone Spine 79:4, pages 365-369.
Crossref
Theodoros Kelesidis, George Daikos, Dimitrios Boumpas & Sotirios Tsiodras. (2011) Does rituximab increase the incidence of infectious complications? A narrative review. International Journal of Infectious Diseases 15:1, pages e2-e16.
Crossref
Annette F. Jansson, Claudia Sengler, Jasmin Kuemmerle-Deschner, Bernd Gruhn, A. Birgitta Kranz, Hartwig Lehmann, Daniela Kleinert, Lars Pape, Hermann J. Girschick, Ivan Foeldvari, Dieter Haffner, Johannes P. Haas, Dagmar Moebius, Dirk Foell, Joachim Peitz & Veit Grote. (2010) B cell depletion for autoimmune diseases in paediatric patients. Clinical Rheumatology 30:1, pages 87-97.
Crossref
Nichola Cooper & Donald M. Arnold. (2010) The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseases. British Journal of Haematology 149:1, pages 3-13.
Crossref
Juan C. Gea-Banacloche. (2010) Rituximab-Associated Infections. Seminars in Hematology 47:2, pages 187-198.
Crossref
L K Hicks, A Woods, R Buckstein, J Mangel, N Pennell, L Zhang, K Imrie, D Spaner, M C Cheung, A Boudreau, M Reis, M Crump & N L Berinstein. (2008) Rituximab purging and maintenance combined with auto-SCT: long-term molecular remissions and prolonged hypogammaglobulinemia in relapsed follicular lymphoma. Bone Marrow Transplantation 43:9, pages 701-708.
Crossref
Liat Vidal, Anat Gafter-Gvili, Leonard Leibovici, Martin Dreyling, Michele Ghielmini, Shu-Fang Hsu Schmitz, Amos Cohen & Ofer Shpilberg. (2009) Rituximab Maintenance for the Treatment of Patients With Follicular Lymphoma: Systematic Review and Meta-analysis of Randomized Trials. JNCI: Journal of the National Cancer Institute 101:4, pages 248-255.
Crossref
Seah H. Lim, William V. Esler, Phillip O. Periman, David Beggs, Yana Zhang & Mary Townsend. (2008) R-CHOP followed by consolidative autologous stem cell transplant and low dose rituxan maintenance therapy for advanced mantle cell lymphoma. British Journal of Haematology 142:3, pages 482-484.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.